Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Lin Zhang in
Google Scholar
PubMed
Search for other papers by Jing Fu in
Google Scholar
PubMed
Search for other papers by Qiu Wang in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
aforementioned metabolic abnormalities, which was called 'metabolically healthy obesity (MHO)' ( 4 , 5 , 6 , 7 ). The precise mechanisms responsible for such a favorable metabolic phenotype in obesity are not entirely understood. Prolactin (PRL) is secreted
Search for other papers by Enrique Soto-Pedre in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
Search for other papers by Paul J Newey in
Google Scholar
PubMed
Search for other papers by John S Bevan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
Search for other papers by Graham P Leese in
Google Scholar
PubMed
recently established by the Prolactin Epidemiology, Audit and Research Study (PROLEARS) – a population-based cohort study in Tayside (Scotland, UK) ( 2 ). This study showed an overall prevalence of hyperprolactinaemia (i.e. prolactin greater than 1000 U
Search for other papers by M von Wolff in
Google Scholar
PubMed
Laboratory of Biometry, University of Thessaly, Volos, Greece
Search for other papers by C T Nakas in
Google Scholar
PubMed
Division of Pneumology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Search for other papers by M Tobler in
Google Scholar
PubMed
Search for other papers by T M Merz in
Google Scholar
PubMed
Search for other papers by M P Hilty in
Google Scholar
PubMed
Search for other papers by J D Veldhuis in
Google Scholar
PubMed
Search for other papers by A R Huber in
Google Scholar
PubMed
Search for other papers by J Pichler Hefti in
Google Scholar
PubMed
−80°C thereafter. Cortisol, prolactin, thyroid-stimulating hormone (TSH), free tetraiodothyronine (fT4), free triiodothyronine (fT3), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone (testosterone) were analysed
Search for other papers by Sarah Byberg in
Google Scholar
PubMed
Search for other papers by Jesper Futtrup in
Google Scholar
PubMed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Jesper Krogh in
Google Scholar
PubMed
Introduction In recent large cohort studies, high prolactin levels within and above the normal physiological range have been associated with increased risk of cardiovascular mortality ( 1 , 2 , 3 ). It is speculated whether this association
Search for other papers by Kazunori Morohoshi in
Google Scholar
PubMed
Search for other papers by Ryo Mochinaga in
Google Scholar
PubMed
Search for other papers by Tsukasa Watanabe in
Google Scholar
PubMed
Search for other papers by Ryojun Nakajima in
Google Scholar
PubMed
Search for other papers by Toshio Harigaya in
Google Scholar
PubMed
Introduction Prolactin (PRL) is a 23 kDa peptide hormone that is mainly produced in the anterior pituitary gland. PRL structurally has three disulfide bonds and four alpha helixes ( 1 , 2 ). N-terminal fragments (11–18 kDa) derived from GH
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Search for other papers by Kathrin H Popp in
Google Scholar
PubMed
Search for other papers by Gunter Karl Stalla in
Google Scholar
PubMed
prolactinoma was based on an enormous highly prolactin value of 10,000 ng/mL (normal range up to 25 ng/mL). The laboratory results at baseline revealed a pituitary insufficiency of the gonadotropic, thyreotropic and corticotropic axis, although stimulation
Search for other papers by Lijin Ji in
Google Scholar
PubMed
Search for other papers by Na Yi in
Google Scholar
PubMed
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Shuo Zhang in
Google Scholar
PubMed
Search for other papers by Xiaoxia Liu in
Google Scholar
PubMed
Search for other papers by Hongli Shi in
Google Scholar
PubMed
Search for other papers by Bin Lu in
Google Scholar
PubMed
–5 patients; 77 (27%) reported having seen no prolactinoma patients. Diagnosis of hyperprolactinemia For patients with prolactin (PRL) <100 ng/mL, 22% of endocrinologists believed that a prolactinoma diagnosis could be ruled out and were more likely to
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
and 2014 were retrospectively analysed. The diagnosis of macroprolactinoma was based on elevated prolactin level (>200 ng/ml) and evidence of pituitary adenoma on magnetic resonance imaging (MRI) with the largest dimension ≥1 cm. Tumours larger than 4
Search for other papers by Caroline Serrano-Nascimento in
Google Scholar
PubMed
Search for other papers by Rafael Barrera Salgueiro in
Google Scholar
PubMed
Search for other papers by Kaio Fernando Vitzel in
Google Scholar
PubMed
Search for other papers by Thiago Pantaleão in
Google Scholar
PubMed
Search for other papers by Vânia Maria Corrêa da Costa in
Google Scholar
PubMed
Search for other papers by Maria Tereza Nunes in
Google Scholar
PubMed
, as described below. Thyroid gland lobes were also prepared for histological analysis. Blood samples were collected to evaluate TSH, T 4 , T 3 and prolactin serum levels. Hearts were excised to determine the wet (WHW) and dry heart weight (DHW) as
Department of Emergency Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Lára Ósk Eggertsdóttir Claessen in
Google Scholar
PubMed
Search for other papers by Hafrún Kristjánsdóttir in
Google Scholar
PubMed
Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland
Search for other papers by María Kristín Jónsdóttir in
Google Scholar
PubMed
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
Search for other papers by Sigrún Helga Lund in
Google Scholar
PubMed
Search for other papers by Ingunn Unnsteinsdóttir Kristensen in
Google Scholar
PubMed
Department of Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Helga Ágústa Sigurjónsdóttir in
Google Scholar
PubMed
). Pituitary gland injury affects the dopaminergic inhibitory control of prolactin release, resulting in rising serum prolactin (s-prolactin) levels ( 30 ). Thus, HPRL may be a sign of pituitary or hypothalamic injury following TBI ( 36 ) and may be a marker of